Before you sell to, join or invest in Salve Therapeutics, Inc.
MentionFox check on Salve Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/salve-therapeutics-inc-form-d-25000001
Check Salve Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Salve Therapeutics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Salve Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-05-02.
Salve Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on May 2, 2025. The filing reports $13K sold. Its industry group is Biotechnology. It names Stefan Lukianov (Executive Officer) (SEC Form D, May 2, 2025).
Is this your company?
Sell to companies like Salve Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Salve Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Salve Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in May 2025, largest first.
Get an email when Salve Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Salve Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Salve Therapeutics, Inc. →Get the full cited report on Salve Therapeutics, Inc.
What the filing shows about Salve Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Salve Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Salve Therapeutics, Inc.'s address as 461 W 6TH St, Suite 201, San Pedro, CA 90731.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Salve Therapeutics, Inc. See pricing
Salve Therapeutics, Inc. is a registered filer with the SEC (CIK 2065545) and has filed since 2025-05-02. 1 filing is on record, the latest on 2025-05-02.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Salve Therapeutics, Inc.'s Form D of 2025-05-02 names Stefan Lukianov as its officers, directors or promoters.
Its new offerings report $13K sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Stefan Lukianov is named as Executive Officer on the Form D that Salve Therapeutics, Inc. filed with the SEC on 2 May 2025, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2025-05-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Salve Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Salve Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Salve Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Salve Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Salve Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Salve Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/salve-therapeutics-inc-form-d-25000001